An efficient synthesis of carbamate analogues of the NRTI compound stavudine, has been achieved in five steps starting from commercially available thymidine. The synthesis involves conversion of thymidine into stavudine followed by condensation with carbaimidazole derivative obtained from various aromatic and heterocyclic amines in dimethylformamide solvent. The analogues thus obtained were further purified by crystallization to furnish analytically pure products. Examination of biological activity of these carbamate derivatives of stavudine showed that they inhibited HIV replication only at micro-molar concentrations.
BalzariniJCooneyDADalalMKangGJCuppJEDe ClercqEBroderS & JohnsDG (1987) 2′,3′-Dideoxycytidine: Regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis. Molecular Pharmacology32: 798–806.
2.
BellFWCantrellASHogbergMJaskunasSRJohanssonNGJordanCLKinnickMDLindPMorinJMJrNoreenRObergBPalkowitzJParrishCAPrancPSahlbergCTernanskyRTVasileffRTVrangLWestSJZhangH & ZhouXX (1995) Phenethylthiazolethiourea compounds as a new class of HIV-1 reverse transcriptase. Journal of Medicinal Chemistry38: 4929–4936.
3.
CantrellASEngelhardtPHogbergMJaskunasSRJohanssonNGJordanCLKangasmetsaJKinnickMDLindPMorinJMJrMuesingMANoreenRObergBPrancPSahlbergCTernanskyRJVasileffRTVrangLWestS J & ZhangH (1996) Phenethylthiazolethiourea compounds as a new class of HIV-1 reverse transcriptase. Journal of Medicinal Chemistry39: 4261–4274.
4.
DeeksSG & VolberdingPA (1997–1998) HIV-1 protease inhibitors. AIDS Clinical Review145–185.
5.
FurmanPAFyfeJASt ClairMHWeinholdKRideoutJLFreemanGANusinoffLSBolognesiDPBroderSMitsuyaH & BarryDW (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proceedings of National Academy of Sciences USA83: 8333–8337.
6.
GoldschmidtRH & DongBJ (1997) Treatment of AIDS and HIV related conditions. Journal of American Board of Family Practioners10: 144–167.
7.
GrobPMWuJCCohenKAIngrahamRHShihCKHargraveKDMcTagueTL & MerluzziVJ (1992) Non nucleoside inhibitors of HIV-1 reverse transcriptase. Human Retrovirus8: 145–152.
8.
HaoZCooneyDAFarquharDPernoCFZhangKMasoodRWilsonYHartmanNRBalzariniJ & JohnsDG (1990) Potent chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2′,3′-dideoxyuridine-5′-triphosphate. Molecular Pharmacology37: 157–163.
9.
HaoZCooneyDAHartmanNRPernoCFFridlandADe VicoALSarngadharanMGBorderS & JohnsDG (1988) Factors determining the activity of 2′,3′-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Molecular Pharmacology34: 431–435.
10.
HorwitzJPChuaJDaRoogeMANoelM & KlindtIL (1966) The formation of 2′,3′-unsaturated pyrimidine nucleosides via a novel b-elimination reaction. Journal of Organic Chemistry31: 205–211.
11.
JohnsonMAAhluwaliaGConnellyMCCooneyDABroderSJohnsDG & FridlandA (1988) Metabolic pathways for the activation of the antiretroviral agent 2′,3′-dideoxyadenosine in human lymphoid cells. Journal of Biological Chemistry263: 15354–15357.
12.
JohnsonMA & FridlanA (1989) Phosphorylation of 2′,3′-dideoxyionsine by cytosolic 5′-nucleotidase of human lymphoid cells. Molecular Pharmacology36: 291–295.
13.
MaoCVigRVenkatachalamTKSudbeckEA & UckunFM (1998) Structure based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic Medicinal Chemistry Letters8: 2213–2218.
14.
MansuriMMStarrettJEJrGhazzouliIHitchcockMJMSterzyckiRZBrankovanVLinTSAugustEMPrussoffWHSommadossiJ-P & MartinJC (1989) 1-(2′,3′-dideoxy-b-D-glycero-pent-2-enfuranosyl)thymine. A highly potent and selective Anti-HIV agent. Journal of Medicinal Chemistry32: 461–466.
15.
McGuiganCPathiranaRNMahmoodNDevineKG & HayAJ (1992) Arylphosphate derivatives of AZT retain their activity against HIV-1 in cell lines which are resistant to the action of AZT. Antiviral Research17: 311–321.
16.
McGuiganCPathiranaRNBalzariniJ & De ClercqE (1993) Intracellular delivery of bioactive AZT nucleotides by arylphosphate derivatives of AZT. Journal of Medicinal Chemistry36: 1048–1052.
17.
McGuiganCCahardDSheekaHMDe ClercqE & BalzariniJ (1996a) Phosphoramidate derivatives of d4T with improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. Journal of Medicinal Chemistry39: 1748–1753.
18.
McGuiganCCahardDSheekaHMDe ClercqE & BalzariniJ (1996b) Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in the thymidine kinase-deficient cells. Biorganic Medicinal Chemistry Letters6: 1183–1186.
19.
StarnesMG & ChengYC (1987) Cellular metabolism of 2′,3′-dideoxy cytidine, a compound active against human immunodeficiency virus in vitro. Journal of Biological Chemistry262: 988–991.
20.
UckunFMChelstromLMTuel-AhlgrenLDibirdikIIrvinJDChandan-LanglieM & MyersDE (1998) TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrobial Agents and Chemotherapy42: 383–388.
21.
UckunFMSamuelPQaziSChenCLPendergrassS & VenkatachalamTK (2002) Effects of arylsubstituents on the anti-HIV activity of the arylphosphoramidate derivatives of stavudine. Antiviral Chemistry & Chemotherapy13: 197–203.
22.
VenkatachalamTKTaiTLVigRChenCLJanST & UckunFM (1998) Enhanced effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of d4T-phenyl methoxyalaninyl phosphate derivatives. Biorganic Medicinal Chemistry Letters8: 3121–3126.
23.
VigRMaoCVenkatachalamTKTuel-AhlgrenLSudbeckEA & UckunFM (1998) Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Biorganic Medicinal Chemistry6: 1789–1797.
24.
VigRVenkatachalamTK & UckunFM (1998) d4T-5′-[p-Bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent. Antiviral Chemistry & Chemotherapy9: 445–448.
25.
USP (2000) United States Pharmacopeia, vol. 24; pp. 2235–2236.
